Core--Biological
$211,997P01FY2002DENIH
Boston Medical Center, Boston MA
Investigators
Linked publications & trials
Paper 20177131Paper 18434581Paper 17905606Paper 17234540Paper 16611224Paper 16428788Paper 16304446Paper 16299299Paper 16253083Paper 16113252Paper 16081595Paper 15790737Paper 15777672Paper 15664935Paper 15562915Paper 15284196Paper 15191547Paper 15123526Paper 15039356Paper 15033911Paper 14525917Paper 14514232Paper 12933833Paper 12765963Paper 12670091Paper 11748192Paper 11748191Paper 11717582Paper 11706944Paper 11673516Paper 11525437
Abstract
The Biological Core will be responsible for extracting and purifying fimbriae, LPS and lipid A from Porphyromonas gingivalis. Standard biochemical techniques will be employed for these procedures. The core will also construct the P. gingivalis fimA deletion mutant. In addition, the core will coordinate the commercial production of polyclonal and monoclonal antibodies to P. gingivalis fimbriae, to the endothelial receptor, to Toll-like proteins and moesin. Finally, the biological core will coordinate sample preparation for nucleotide and peptide sequencing and flow cytometry.
View original record on NIH RePORTER →